131 related articles for article (PubMed ID: 35596107)
41. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
42. Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.
Wassner AJ; Jugo RH; Dorfman DM; Padera RF; Maynard MA; Zavacki AM; Jay PY; Huang SA
Thyroid; 2017 May; 27(5):732-737. PubMed ID: 28314380
[TBL] [Abstract][Full Text] [Related]
43. Deep sequence analysis of gene expression identifies osteopontin as a downstream effector of integrin-linked kinase (ILK) in cardiac-specific ILK knockout mice.
Dai J; Matsui T; Abel ED; Dedhar S; Gerszten RE; Seidman CE; Seidman JG; Rosenzweig A
Circ Heart Fail; 2014 Jan; 7(1):184-93. PubMed ID: 24319095
[TBL] [Abstract][Full Text] [Related]
44. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
[TBL] [Abstract][Full Text] [Related]
45. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Xu Z; Mei F; Liu H; Sun C; Zheng Z
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
[TBL] [Abstract][Full Text] [Related]
46. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-κB and MAPKs signaling pathways modulated by ROS generation.
Lin B; Xu J; Feng DG; Wang F; Wang JX; Zhao H
Biochem Biophys Res Commun; 2018 Jun; 501(1):24-32. PubMed ID: 29660332
[TBL] [Abstract][Full Text] [Related]
47. Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model.
Rapti K; Diokmetzidou A; Kloukina I; Milner DJ; Varela A; Davos CH; Capetanaki Y
Free Radic Biol Med; 2017 Sep; 110():206-218. PubMed ID: 28629836
[TBL] [Abstract][Full Text] [Related]
48. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
[TBL] [Abstract][Full Text] [Related]
49. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
Schmitt JP; Kamisago M; Asahi M; Li GH; Ahmad F; Mende U; Kranias EG; MacLennan DH; Seidman JG; Seidman CE
Science; 2003 Feb; 299(5611):1410-3. PubMed ID: 12610310
[TBL] [Abstract][Full Text] [Related]
50. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene.
Muchir A; Reilly SA; Wu W; Iwata S; Homma S; Bonne G; Worman HJ
Cardiovasc Res; 2012 Feb; 93(2):311-9. PubMed ID: 22068161
[TBL] [Abstract][Full Text] [Related]
51. Principal strain changes precede ventricular wall thinning during transition to heart failure in a mouse model of dilated cardiomyopathy.
Hankiewicz JH; Goldspink PH; Buttrick PM; Lewandowski ED
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H330-6. PubMed ID: 17965277
[TBL] [Abstract][Full Text] [Related]
52. Phosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways.
Dickinson RJ; Delavaine L; Cejudo-Marín R; Stewart G; Staples CJ; Didmon MP; Trinidad AG; Alonso A; Pulido R; Keyse SM
J Biol Chem; 2011 Nov; 286(44):38018-38026. PubMed ID: 21908610
[TBL] [Abstract][Full Text] [Related]
53. Structure of human dual-specificity phosphatase 7, a potential cancer drug target.
Lountos GT; Austin BP; Tropea JE; Waugh DS
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):650-6. PubMed ID: 26057789
[TBL] [Abstract][Full Text] [Related]
54. Pivotal Role of Regulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy.
Huang J; Chen L; Yao Y; Tang C; Ding J; Fu C; Li H; Ma G
Hypertension; 2016 Jun; 67(6):1228-36. PubMed ID: 27091895
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway.
Ha J; Kang E; Seo J; Cho S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817617
[TBL] [Abstract][Full Text] [Related]
56. Dual specificity phosphatase 9 (DUSP9) expression is down-regulated in the severe pre-eclamptic placenta.
Czikk MJ; Drewlo S; Baczyk D; Adamson SL; Kingdom J
Placenta; 2013 Feb; 34(2):174-81. PubMed ID: 23276385
[TBL] [Abstract][Full Text] [Related]
57. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
[TBL] [Abstract][Full Text] [Related]
58. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.
Jain M; Jakubowski A; Cui L; Shi J; Su L; Bauer M; Guan J; Lim CC; Naito Y; Thompson JS; Sam F; Ambrose C; Parr M; Crowell T; Lincecum JM; Wang MZ; Hsu YM; Zheng TS; Michaelson JS; Liao R; Burkly LC
Circulation; 2009 Apr; 119(15):2058-68. PubMed ID: 19349318
[TBL] [Abstract][Full Text] [Related]
59. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
[TBL] [Abstract][Full Text] [Related]
60. Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability.
Chen HF; Chuang HC; Tan TH
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]